These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33432417)

  • 1. Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy.
    Baumeier C; Escher F; Aleshcheva G; Pietsch H; Schultheiss HP
    Basic Res Cardiol; 2021 Jan; 116(1):1. PubMed ID: 33432417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac macrophages adopt profibrotic/M2 phenotype in infarcted hearts: Role of urokinase plasminogen activator.
    Carlson S; Helterline D; Asbe L; Dupras S; Minami E; Farris S; Stempien-Otero A
    J Mol Cell Cardiol; 2017 Jul; 108():42-49. PubMed ID: 27262672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neu1 deficiency and fibrotic lymph node microenvironment lead to imbalance in M1/M2 macrophage polarization.
    Escalona E; Olate-Briones A; Albornoz-Muñoz S; Bonacic-Doric E; Rodríguez-Arriaza F; Herrada AA; Escobedo N
    Front Immunol; 2024; 15():1462853. PubMed ID: 39346907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neural cell adhesion molecule expression in dilated cardiomyopathy is associated with intramyocardial inflammation and hypertrophy.
    Ostermann K; Schultheiss HP; Noutsias M
    Int J Cardiol; 2017 Aug; 241():322-325. PubMed ID: 28343767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy.
    Wu L; Ong S; Talor MV; Barin JG; Baldeviano GC; Kass DA; Bedja D; Zhang H; Sheikh A; Margolick JB; Iwakura Y; Rose NR; Ciháková D
    J Exp Med; 2014 Jun; 211(7):1449-64. PubMed ID: 24935258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis.
    Huang WT; Vayalil PK; Miyata T; Hagood J; Liu RM
    Am J Respir Cell Mol Biol; 2012 Jan; 46(1):87-95. PubMed ID: 21852684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of the presence of macrophages in endomyocardial biopsies of patients with dilated cardiomyopathy.
    Nakayama T; Sugano Y; Yokokawa T; Nagai T; Matsuyama TA; Ohta-Ogo K; Ikeda Y; Ishibashi-Ueda H; Nakatani T; Ohte N; Yasuda S; Anzai T
    Eur J Heart Fail; 2017 Apr; 19(4):490-498. PubMed ID: 28217949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation.
    Gupta KK; Donahue DL; Sandoval-Cooper MJ; Castellino FJ; Ploplis VA
    Sci Rep; 2017 Mar; 7(1):365. PubMed ID: 28336948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy.
    Chen P; Xie Y; Shen E; Li GG; Yu Y; Zhang CB; Yang Y; Zou Y; Ge J; Chen R; Chen H
    Eur J Pharmacol; 2011 May; 658(2-3):168-74. PubMed ID: 21371462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts.
    Omori K; Hattori N; Senoo T; Takayama Y; Masuda T; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Kohno N
    PLoS One; 2016; 11(2):e0148969. PubMed ID: 26859294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer.
    Kubala MH; Punj V; Placencio-Hickok VR; Fang H; Fernandez GE; Sposto R; DeClerck YA
    Cell Rep; 2018 Nov; 25(8):2177-2191.e7. PubMed ID: 30463014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosis.
    Wang S; Meng XM; Ng YY; Ma FY; Zhou S; Zhang Y; Yang C; Huang XR; Xiao J; Wang YY; Ka SM; Tang YJ; Chung AC; To KF; Nikolic-Paterson DJ; Lan HY
    Oncotarget; 2016 Feb; 7(8):8809-22. PubMed ID: 26684242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of functional T-cell markers and T-cell receptor Vbeta repertoire in endomyocardial biopsies from patients presenting with acute myocarditis and dilated cardiomyopathy.
    Noutsias M; Rohde M; Göldner K; Block A; Blunert K; Hemaidan L; Hummel M; Blohm JH; Lassner D; Kühl U; Schultheiss HP; Volk HD; Kotsch K
    Eur J Heart Fail; 2011 Jun; 13(6):611-8. PubMed ID: 21422001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. M1- and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3.
    Wijesundera KK; Izawa T; Tennakoon AH; Murakami H; Golbar HM; Katou-Ichikawa C; Tanaka M; Kuwamura M; Yamate J
    Exp Mol Pathol; 2014 Jun; 96(3):382-92. PubMed ID: 24747241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
    Lian R; Chen Y; Xu Z; Zhang X
    Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endomyocardial miR-133a levels correlate with myocardial inflammation, improved left ventricular function, and clinical outcome in patients with inflammatory cardiomyopathy.
    Besler C; Urban D; Watzka S; Lang D; Rommel KP; Kandolf R; Klingel K; Thiele H; Linke A; Schuler G; Adams V; Lurz P
    Eur J Heart Fail; 2016 Dec; 18(12):1442-1451. PubMed ID: 27292200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAI-1 mediates TGF-β1-induced myofibroblast activation in tenocytes via mTOR signaling.
    Alenchery RG; Ajalik RE; Jerreld K; Midekksa F; Zhong S; Alkatib B; Awad HA
    J Orthop Res; 2023 Oct; 41(10):2163-2174. PubMed ID: 37143206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.